JNK Inhibition Reduced Retinal Ganglion Cell Death after Ischemia/Reperfusion In Vivo and after Hypoxia In Vitro

Area of Science:

• Cell Biology
• Neuroscience
• Ophthalmology

Background:

• Mitogen-activated protein kinases (MAPKs) regulate cell survival and death pathways.
• c-jun N-terminal kinase (JNK) is implicated in cellular stress responses and apoptosis.

Purpose of the Study:

• To investigate the role of JNK in hypoxia- and intraocular pressure (IOP)-induced retinal cell death.
• To evaluate the protective potential of a JNK inhibitor (D-JNKi) against retinal ischemia/reperfusion injury.

Main Methods:

• In vitro studies using 661W cells exposed to hypoxia.
• In vivo studies involving rats with elevated IOP.
• Assessment of JNK activity and apoptosis.
• Administration of D-JNKi to inhibit JNK activation.

Main Results:

• Hypoxia increased 661W cell death, JNK, and c-jun activity in vitro.
• D-JNKi treatment reduced hypoxia-induced cell death in 661W cells.
• Elevated IOP in rats correlated with altered JNK activation and retinal cell apoptosis.
• In vivo D-JNKi administration significantly decreased apoptosis in multiple retinal layers.

Conclusions:

• JNK activation plays a critical role in retinal cell death induced by stress conditions like hypoxia and elevated IOP.
• Inhibiting JNK with D-JNKi demonstrates a protective effect against retinal ischemia/reperfusion injury.
• Targeting JNK pathways offers a promising therapeutic strategy for retinal neuroprotection.